Balance Sheet
Cash Flow Statement
Net Income
Growth Metrics
Income Statement
Others
Ratios

Innate Pharma (IPHYF) Change in Cash (2019 - 2024)

Historic Change in Cash for Innate Pharma (IPHYF) over the last 6 years, with Q4 2024 value amounting to -$4.5 million.

  • Innate Pharma's Change in Cash rose 6930.56% to -$4.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$33.1 million, marking a year-over-year increase of 3298.06%. This contributed to the annual value of -$4.5 million for FY2024, which is 6930.56% up from last year.
  • As of Q4 2024, Innate Pharma's Change in Cash stood at -$4.5 million, which was up 6930.56% from -$1076.9 recorded in Q2 2024.
  • Innate Pharma's 5-year Change in Cash high stood at -$1076.9 for Q2 2024, and its period low was -$78.8 million during Q4 2020.
  • For the 5-year period, Innate Pharma's Change in Cash averaged around -$28.9 million, with its median value being -$17.3 million (2023).
  • Its Change in Cash has fluctuated over the past 5 years, first plummeted by 228042.03% in 2020, then surged by 9999.23% in 2024.
  • Innate Pharma's Change in Cash (Quarter) stood at -$78.8 million in 2020, then surged by 52.04% to -$37.8 million in 2021, then soared by 47.27% to -$19.9 million in 2022, then rose by 26.47% to -$14.7 million in 2023, then surged by 69.31% to -$4.5 million in 2024.
  • Its Change in Cash was -$4.5 million in Q4 2024, compared to -$1076.9 in Q2 2024 and -$14.7 million in Q4 2023.